{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-017641","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.944609+00:00","generated_at":"2026-05-16T02:06:55.577807+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bluejay Diagnostics enrolls 545 patients in SYMON™ II study, exceeds expectations","bullets":["Enrolled 545 of 750 target patients in SYMON™ II multicenter IL-6 monitoring study, exceeding initial expectations.","Completed monoclonal and polyclonal antibody production, providing capacity for >10 million test cartridges.","Manufacturing readiness includes cartridge characterization for U.S. commercial production and ongoing fabrication for FDA submission.","Company transitions focus to data analysis, regulatory engagement, and commercialization preparedness in 2026.","Technology transfer activities progress without single point of failure, mitigating scale-up risk."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-017641","json":"https://secwatch.observer/filing/0001213900-26-017641.json","markdown":"https://secwatch.observer/filing/0001213900-26-017641.md","text":"https://secwatch.observer/filing/0001213900-26-017641.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026017641/0001213900-26-017641-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026017641/ea0277474-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:06:55.577807+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}